Death-Signaling Pathways In Human Myeloid Cells By Oxldl and Its Cytotoxic Components 7 Beta-Hydroxycholesterol and Cholesterol-5 Beta,6 Beta-Epoxide

Typeset version

 

TY  - JOUR
  - Lordan, S, O'Callaghan, YC, O'Brien, NM
  - 2007
  - July
  - Journal of Biochemical and Molecular Toxicology
  - Death-Signaling Pathways In Human Myeloid Cells By Oxldl and Its Cytotoxic Components 7 Beta-Hydroxycholesterol and Cholesterol-5 Beta,6 Beta-Epoxide
  - Validated
  - ()
  - 21
  - 6
  - 362
  - 372
  - Oxidized low-density lipoprotein contains many potentially proatherogenic molecules, including oxysterols, which have been shown to induce apoptosis in various cell lines. The aim of this study was to investigate the pathway of apoptosis induced by oxidized low-density lipoprotein and the oxysterols, 7 beta-hydroxycholesterol and cholesterol-5 beta,6 beta-pepoxide, in two human monocytic cell lines. The HL-60 cells appeared to be more sensitive to oxidized low-density lipoprotein than U937 cells, whereas the isolated oxysterols were more potent inducers of apoptosis in the U937 cells. Caspase-2 inhibition decreased the number of viable cells in oxidized low-density lipoprotein-treated samples; however, it protected against cholesterol-5 beta,6 beta-epoxide-induced cell death. Western blot analysis was utilized to examine the effect of caspase-2 inhibition on the expression of the antiapoptotic protein Bcl-2. Pretreatment with the inhibitor protected against the decrease in Bcl-2 expression in oxidized low-density lipoprotein and 7 beta-hydroxycholesterol-treated U937 cells. In HL-60 cells, Bcl-2 was overexpressed in oxidized low-density lipoprotein-treated cells, but in the presence of the inhibitor Bcl-2 expression was returned to control levels. Depleted ATP concentrations in the cells suggest that both apoptosis and necrosis may have occurred simultaneously. Our results highlight differences in the signaling pathways induced by oxidized low-density lipoprotein, 7 beta-hydroxycholesterol, and cholesterol-5 beta,6 beta-epoxide in U937and HL-60 cells. (c) 2007 Wiley Periodicals, Inc..
DA  - 2007/07
ER  - 
@article{V725318,
   = {Lordan,  S and  O'Callaghan,  YC and  O'Brien,  NM },
   = {2007},
   = {July},
   = {Journal of Biochemical and Molecular Toxicology},
   = {Death-Signaling Pathways In Human Myeloid Cells By Oxldl and Its Cytotoxic Components 7 Beta-Hydroxycholesterol and Cholesterol-5 Beta,6 Beta-Epoxide},
   = {Validated},
   = {()},
   = {21},
   = {6},
  pages = {362--372},
   = {{Oxidized low-density lipoprotein contains many potentially proatherogenic molecules, including oxysterols, which have been shown to induce apoptosis in various cell lines. The aim of this study was to investigate the pathway of apoptosis induced by oxidized low-density lipoprotein and the oxysterols, 7 beta-hydroxycholesterol and cholesterol-5 beta,6 beta-pepoxide, in two human monocytic cell lines. The HL-60 cells appeared to be more sensitive to oxidized low-density lipoprotein than U937 cells, whereas the isolated oxysterols were more potent inducers of apoptosis in the U937 cells. Caspase-2 inhibition decreased the number of viable cells in oxidized low-density lipoprotein-treated samples; however, it protected against cholesterol-5 beta,6 beta-epoxide-induced cell death. Western blot analysis was utilized to examine the effect of caspase-2 inhibition on the expression of the antiapoptotic protein Bcl-2. Pretreatment with the inhibitor protected against the decrease in Bcl-2 expression in oxidized low-density lipoprotein and 7 beta-hydroxycholesterol-treated U937 cells. In HL-60 cells, Bcl-2 was overexpressed in oxidized low-density lipoprotein-treated cells, but in the presence of the inhibitor Bcl-2 expression was returned to control levels. Depleted ATP concentrations in the cells suggest that both apoptosis and necrosis may have occurred simultaneously. Our results highlight differences in the signaling pathways induced by oxidized low-density lipoprotein, 7 beta-hydroxycholesterol, and cholesterol-5 beta,6 beta-epoxide in U937and HL-60 cells. (c) 2007 Wiley Periodicals, Inc..}},
  source = {IRIS}
}
AUTHORSLordan, S, O'Callaghan, YC, O'Brien, NM
YEAR2007
MONTHJuly
JOURNAL_CODEJournal of Biochemical and Molecular Toxicology
TITLEDeath-Signaling Pathways In Human Myeloid Cells By Oxldl and Its Cytotoxic Components 7 Beta-Hydroxycholesterol and Cholesterol-5 Beta,6 Beta-Epoxide
STATUSValidated
TIMES_CITED()
SEARCH_KEYWORD
VOLUME21
ISSUE6
START_PAGE362
END_PAGE372
ABSTRACTOxidized low-density lipoprotein contains many potentially proatherogenic molecules, including oxysterols, which have been shown to induce apoptosis in various cell lines. The aim of this study was to investigate the pathway of apoptosis induced by oxidized low-density lipoprotein and the oxysterols, 7 beta-hydroxycholesterol and cholesterol-5 beta,6 beta-pepoxide, in two human monocytic cell lines. The HL-60 cells appeared to be more sensitive to oxidized low-density lipoprotein than U937 cells, whereas the isolated oxysterols were more potent inducers of apoptosis in the U937 cells. Caspase-2 inhibition decreased the number of viable cells in oxidized low-density lipoprotein-treated samples; however, it protected against cholesterol-5 beta,6 beta-epoxide-induced cell death. Western blot analysis was utilized to examine the effect of caspase-2 inhibition on the expression of the antiapoptotic protein Bcl-2. Pretreatment with the inhibitor protected against the decrease in Bcl-2 expression in oxidized low-density lipoprotein and 7 beta-hydroxycholesterol-treated U937 cells. In HL-60 cells, Bcl-2 was overexpressed in oxidized low-density lipoprotein-treated cells, but in the presence of the inhibitor Bcl-2 expression was returned to control levels. Depleted ATP concentrations in the cells suggest that both apoptosis and necrosis may have occurred simultaneously. Our results highlight differences in the signaling pathways induced by oxidized low-density lipoprotein, 7 beta-hydroxycholesterol, and cholesterol-5 beta,6 beta-epoxide in U937and HL-60 cells. (c) 2007 Wiley Periodicals, Inc..
PUBLISHER_LOCATION
ISBN_ISSN
EDITION
URL
DOI_LINK
FUNDING_BODY
GRANT_DETAILS